相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ensemble-based high-throughput virtual screening of natural ligands using the Super Natural-II database against cell-wall protein dTDP-4-dehydrorhamnose reductase (RmlD) in Mycobacterium tuberculosis
Rahul Ravichandran et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis The COMRADE Randomized, Phase 2A Clinical Trial
Veronique De Jager et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Triclosan induces apoptosis in Burkitt lymphoma-derived BJAB cells through caspase and JNK/MAPK pathways
Mohammad A. Alfhili et al.
APOPTOSIS (2021)
Mycobacterium enoyl acyl carrier protein reductase (InhA): A key target for antitubercular drug discovery
Mayuri S. Prasad et al.
BIOORGANIC CHEMISTRY (2021)
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules
Wei Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Unique C-terminal extension and interactome of Mycobacterium tuberculosis GlmU impacts it's in vivo function and the survival of pathogen
Meetu Agarwal et al.
BIOCHEMICAL JOURNAL (2021)
An Alternative and Conserved Cell Wall Enzyme That Can Substitute for the Lipid II Synthase MurG
L. Zhang et al.
MBIO (2021)
Mycobacterium tuberculosis Thymidylyltransferase RmlA Is Negatively Regulated by Ser/Thr Protein Kinase PknB
Dehui Qu et al.
FRONTIERS IN MICROBIOLOGY (2021)
Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832
Gregory T. Robertson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
A multi-targeting pre-clinical candidate against drug-resistant tuberculosis
Parvinder Kaur et al.
TUBERCULOSIS (2021)
Repurposing of FDA-approved drugs to target MurB and MurE enzymes in Mycobacterium tuberculosis
Jyoti Rani et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
An overview of new antitubercular drugs, drug candidates, and their targets
Aparna Bahuguna et al.
MEDICINAL RESEARCH REVIEWS (2020)
Gestational and lactational exposure to triclosan causes impaired fertility of F1 male offspring and developmental defects in F2 generation
Priyanka et al.
ENVIRONMENTAL POLLUTION (2020)
Identification of peptidomimetic compounds as potential inhibitors against MurA enzyme of Mycobacterium tuberculosis
Prateek Kumar et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Structures of Mycobacterium tuberculosis Penicillin-Binding Protein 3 in Complex with Five β-Lactam Antibiotics Reveal Mechanism of Inactivation
Zuokun Lu et al.
MOLECULAR PHARMACOLOGY (2020)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Francesca Conradie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor
Norimitsu Hariguchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol
Lu Zhang et al.
SCIENCE (2020)
Cryo-EM Structures and Regulation of Arabinofuranosyltransferase AftD from Mycobacteria
Yong Zi Tan et al.
MOLECULAR CELL (2020)
Delamanid Resistance: Update and Clinical Management
Thi Van Anh Nguyen et al.
CLINICAL INFECTIOUS DISEASES (2020)
On tuberculosis and COVID-19 co-infection
Marina Tadolini et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Activity-Based Protein Profiling Reveals That Cephalosporins Selectively Active on Non-replicating Mycobacterium tuberculosis Bind Multiple Protein Families and Spare Peptidoglycan Transpeptidases
Landys Lopez Quezada et al.
FRONTIERS IN MICROBIOLOGY (2020)
Cryo-EM structure of arabinosyltransferase EmbB from Mycobacterium smegmatis
Yong Zi Tan et al.
NATURE COMMUNICATIONS (2020)
Hydroxylation of Antitubercular Drug Candidate, SQ109, by Mycobacterial Cytochrome P450
Sergey Bukhdruker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors
Matthew B. McNeil et al.
MSPHERE (2020)
A Preclinical Candidate Targeting Mycobacterium tuberculosis KasA
Daigo Inoyama et al.
CELL CHEMICAL BIOLOGY (2020)
Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis
Jian Xu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
Bing Zhang et al.
CELL (2019)
The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis
Catherine Vilcheze et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Lack of association of novel mutation Asp397Gly in aftB gene with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis
Astha Giri et al.
TUBERCULOSIS (2019)
Drug repurposing against arabinosyl transferase (EmbC) of Mycobacterium tuberculosis: Essential dynamics and free energy minima based binding mechanics analysis
Aditi Singh et al.
GENE (2019)
The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis
Rainer Kalscheuer et al.
BIOCHEMICAL JOURNAL (2019)
Action of Dicumarol on Glucosamine-1-Phosphate Acetyltransferase of GlmU and Mycobacterium tuberculosis
Xiuyan Han et al.
FRONTIERS IN MICROBIOLOGY (2019)
BPaL approved for multidrug-resistant tuberculosis
Talha Burki
LANCET INFECTIOUS DISEASES (2019)
Streptococcal dTDP-L-rhamnose biosynthesis enzymes: functional characterization and lead compound identification
Samantha L. van der Beek et al.
MOLECULAR MICROBIOLOGY (2019)
A structural and functional perspective on the enzymes of Mycobacterium tuberculosis involved in the L-rhamnose biosynthesis pathway
Devendra K. Dhaked et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2019)
Pathogenesis of HIV-1 and Mycobacterium tuberculosis co-infection
Lucy C. K. Bell et al.
NATURE REVIEWS MICROBIOLOGY (2018)
Validation of Cycloserine Efficacy in Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Beijing, China
Xia Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Synthesis of Avibactam Derivatives and Activity on β-Lactamases and Peptidoglycan Biosynthesis Enzymes of Mycobacteria
Zainab Edoo et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Triclosan and its derivatives as antimycobacterial active agents
Rudolf Vosatka et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Virtual Screening of Small Molecular Inhibitors against DprE1
Gang Zhang et al.
MOLECULES (2018)
Maternal urinary triclosan level, gestational diabetes mellitus and birth weight in Chinese women
Fengxiu Ouyang et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2018)
Crystallization and structure analysis of the core motif of the Pks13 acyltransferase domain from Mycobacterium tuberculosis
Mingjing Yu et al.
PEERJ (2018)
Peptidoglycan in Mycobacteria: chemistry, biology and intervention
Tripti Raghavendra et al.
GLYCOCONJUGATE JOURNAL (2018)
Drug resistance mechanisms and drug susceptibility testing for tuberculosis
Paolo Miotto et al.
RESPIROLOGY (2018)
Chemistry of Peptidoglycan in Mycobacterium tuberculosis Life Cycle: An off-the-wall Balance of Synthesis and Degradation
Flavia Squeglia et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Ceftazidime-avibactam has potent sterilizing activity against highly drug-resistant tuberculosis
Devyani Deshpande et al.
SCIENCE ADVANCES (2017)
Cell wall: A versatile fountain of drug targets in Mycobacterium tuberculosis
Zubair Shanib Bhat et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Mur Ligase Inhibitors as Anti-bacterials: A Comprehensive Review
Jaiprakash N. Sangshetti et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13
Anup Aggarwal et al.
CELL (2017)
Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro
Wei Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The changes in mycolic acid structures caused by hadC mutation have a dramatic effect on the virulence of Mycobacterium tuberculosis
Nawel Slama et al.
MOLECULAR MICROBIOLOGY (2016)
N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-Dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity
Ana Guardia et al.
CHEMMEDCHEM (2016)
UDP-GlcNAc pathway: Potential target for inhibitor discovery against M-tuberculosis
Chitra Rani et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
Simon Tiberi et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Assembly of the Mycobacterial Cell Wall
Monika Jankute et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 69 (2015)
Hydrolysis of Clavulanate by Mycobacterium tuberculosis β-Lactamase BlaC Harboring a Canonical SDN Motif
Daria Soroka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles
Affiba Florance Kouassi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Norbert Heinrich et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
GtrA Protein Rv3789 Is Required for Arabinosylation of Arabinogalactan in Mycobacterium tuberculosis
Gaelle S. Kolly et al.
JOURNAL OF BACTERIOLOGY (2015)
Direct inhibitors of InhA are active against Mycobacterium tuberculosis
Ujjini H. Manjunatha et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The Mycobacterial Cell Wall-Peptidoglycan and Arabinogalactan
Luke J. Alderwick et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors
Shajila Siricilla et al.
JOURNAL OF ANTIBIOTICS (2015)
Structure, Dynamics, and Interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 Examined by Molecular Modeling, Simulation, and Electrostatic Studies
Isha Bhutani et al.
PLOS ONE (2015)
Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I
Shajila Siricilla et al.
ANALYTICAL BIOCHEMISTRY (2014)
Novel Insights into the Mechanism of Inhibition of MmpL3, a Target of Multiple Pharmacophores in Mycobacterium tuberculosis
Wei Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
1,4-Azaindole, a Potential Drug Candidate for Treatment of Tuberculosis
Monalisa Chatterji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Towards a new combination therapy for tuberculosis with next generation benzothiazinones
Vadim Makarov et al.
EMBO MOLECULAR MEDICINE (2014)
Rational design of InhA inhibitors in the class of diphenyl ether derivatives as potential anti-tubercular agents using molecular dynamics simulations
P. Kamsri et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2014)
Phosphorylation of KasB Regulates Virulence and Acid-Fastness in Mycobacterium tuberculosis
Catherine Vilcheze et al.
PLOS PATHOGENS (2014)
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities
Catherine Vilcheze et al.
MICROBIOLOGY SPECTRUM (2014)
Delamanid: A new armor in combating drug-resistant tuberculosis
Alphienes Stanley Xavier et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2014)
Kinetic mechanism and inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by the antibiotic D-cycloserine
Gareth A. Prosser et al.
FEBS JOURNAL (2013)
Inhibition of the First Step in Synthesis of the Mycobacterial Cell Wall Core, Catalyzed by the GlcNAc-1-phosphate Transferase WecA, by the Novel Caprazamycin Derivative CPZEN-45
Yoshimasa Ishizaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo
Pravin S. Shirude et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Clarification on the Decarboxylation Mechanism in KasA Based on the Protonation State of Key Residues in the Acyl-Enzyme State
Wook Lee et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis
Regina Wilson et al.
NATURE CHEMICAL BIOLOGY (2013)
Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
Thomas R. Ioerger et al.
PLOS ONE (2013)
Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
Srinivasa P. S. Rao et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Biopharmaceutical in vitro characterization of CPZEN-45, a drug candidate for inhalation therapy of tuberculosis
Johanna J. Salomon et al.
THERAPEUTIC DELIVERY (2013)
Inactivation of Mycobacterium tuberculosis L,D-Transpeptidase LdtMt1 by Carbapenems and Cephalosporins
Vincent Dubee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action
Katherine A. Sacksteder et al.
FUTURE MICROBIOLOGY (2012)
Arabinogalactan and lipoarabinomannan biosynthesis: structure, biogenesis and their potential as drug targets
Monika Jankute et al.
FUTURE MICROBIOLOGY (2012)
Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
Anna E. Grzegorzewicz et al.
NATURE CHEMICAL BIOLOGY (2012)
Reconstitution of Functional Mycobacterial Arabinosyltransferase AftC Proteoliposome and Assessment of Decaprenylphosphorylarabinose Analogues as Arabinofuranosyl Donors
Jian Zhang et al.
ACS CHEMICAL BIOLOGY (2011)
Development of isoniazid-NAD truncated adducts embedding a lipophilic fragment as potential bi-substrate InhA inhibitors and antimycobacterial agents
Tamara Delaine et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Benzothiazinones: Prodrugs That Covalently Modify the Decaprenylphosphoryl-β-D-ribose 2′-epimerase DprE1 of Mycobacterium tuberculosis
Claudia Trefzer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Jose A. Caminero et al.
LANCET INFECTIOUS DISEASES (2010)
The Mycobacterium tuberculosis protein LdtMt2 is a nonclassical transpeptidase required for virulence and resistance to amoxicillin
Radhika Gupta et al.
NATURE MEDICINE (2010)
Triclosan Derivatives: Towards Potent Inhibitors of Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis
Joel S. Freundlich et al.
CHEMMEDCHEM (2009)
Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death
Jordi B. Torrelles et al.
GLYCOBIOLOGY (2009)
The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosis
Sabine Gavalda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov et al.
SCIENCE (2009)
The peptidoglycan of stationary-phase Mycobacterium tuberculosis predominantly contains cross-links generated by L,D-transpeptidation
Marie Lavollay et al.
JOURNAL OF BACTERIOLOGY (2008)
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Ramandeep Singh et al.
SCIENCE (2008)
Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides
Xin Hea et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Structure, function and biosynthesis of the Mycobacterium tuberculosis cell wall:: arabinogalactan and lipoarabinomannan assembly with a view to discovering new drug targets
L. J. Alderwick et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Irreversible inhibition of the mycobacterium tuberculosis β-lactarnase by clavulanate
Jean-Emmanuel Hugonnet et al.
BIOCHEMISTRY (2007)
The missing piece of the type II fatty acid synthase system from Mycobacterium tuberculosis
Emmanuelle Sacco et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Evaluation of N-(phenylmethyl)-4-[5-(phenylmethyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-4-yl]benzamide inhibitors of Mycobacterium tuberculosis growth
Michael D. Wall et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Functional complementation of the essential gene fabG1 of Mycobacterium tuberculosis by Mycobacterium smegmatis fabG but not Escherichia coli fabG
Tanya Parish et al.
JOURNAL OF BACTERIOLOGY (2007)
OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice
Makoto Matsumoto et al.
PLOS MEDICINE (2006)
rmlB and rmlC genes are essential fair growth with mycobacteria
W Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Identification and characterization of Rv3281 as a novel subunit of a biotin-dependent Acyl-CoA carboxylase in Mycobacterium tuberculosis H37Rv
TJ Oh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis
A Bhatt et al.
JOURNAL OF BACTERIOLOGY (2005)
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis
S Tyagi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models
AJ Lenaerts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Contribution of the Mycobacterium tuberculosis MmpL protein family to virulence and drug resistance
P Domenech et al.
INFECTION AND IMMUNITY (2005)
The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth -: Identification of the carboxylation product and determination of the acyl-CoA carboxylase components
D Portevin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms
D Portevin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
β-ketoacyl-acyl carrier protein synthase III (FabH) is essential for bacterial fatty acid synthesis
CY Lai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA:AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II
L Kremer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis
L Kremer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
